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RESEARCH PAPER
Auditory training changes temporal lobe connectivity 
in ‘Wernicke’s aphasia’: a randomised trial
Zoe VJ Woodhead,1,2,3 Jennifer Crinion,4 Sundeep Teki,5 Will  Penny,2 Cathy J  Price,2 
Alexander P  Leff 2,4
ABSTRACT
Introduction  Aphasia is one of the most disabling se-
quelae after stroke, occurring in 25%–40% of stroke sur-
vivors. However, there remains a lack of good evidence 
for the efficacy or mechanisms of speech comprehension 
rehabilitation. 
Trial Design  This within-subjects trial tested 
two concurrent interventions in 20 patients with 
chronic aphasia with speech comprehension 
impairment following left hemisphere stroke: (1) 
phonological training using ‘Earobics’ software and 
(2) a pharmacological intervention using donepezil, an 
acetylcholinesterase inhibitor. Donepezil was tested in a 
double-blind, placebo-controlled, cross-over design using 
block randomisation with bias minimisation. 
Methods  The primary outcome measure was speech 
comprehension score on the comprehensive aphasia test. 
Magnetoencephalography (MEG) with an established 
index of auditory perception, the mismatch negativity 
response, tested whether the therapies altered effective 
connectivity at the lower (primary) or higher (secondary) 
level of the auditory network. 
Results  Phonological training improved speech 
comprehension abilities and was particularly effective 
for patients with severe deficits. No major adverse 
effects of donepezil were observed, but it had an 
unpredicted negative effect on speech comprehension. 
The MEG analysis demonstrated that phonological 
training increased synaptic gain in the left superior 
temporal gyrus (STG). Patients with more severe speech 
comprehension impairments also showed strengthening 
of bidirectional connections between the left and right 
STG. 
Conclusions  Phonological training resulted in a small 
but significant improvement in speech comprehension, 
whereas donepezil had a negative effect. The connectivity 
results indicated that training reshaped higher order 
phonological representations in the left STG and (in 
more severe patients) induced stronger interhemispheric 
transfer of information between higher levels of auditory 
cortex. Clinical trial registration This trial was registered 
with EudraCT (2005-004215-30, https:// eudract . ema. 
europa. eu ) and ISRCTN (68939136, http://www. isrctn. 
com ).
INTRODUCTION
Speech comprehension impairments after stroke 
caused by damage to dominant temporoparietal 
cortex (ie, 'Wernicke’s aphasia' (WA) and global 
aphasia)1–3 are resistant to treatment by conven-
tional methods4; hence, there is a need for new 
evidence-based therapies to improve auditory 
comprehension in aphasia.
One popular target for WA therapy is the low-level 
deficit in auditory phonological analysis.5–7 This 
typically involves training auditory discrimina-
tion with phonemes, consonant-vowel-consonant 
segments or longer sequences. Previous attempts 
have met with mixed results: whereas two case 
studies reported positive effects on auditory 
discrimination and/or comprehension,8 9 a further 
case study10 and case series of eight patients11 failed 
to find any significant improvements. We tested the 
efficacy of phonological training using Earobics 
software12 in a larger sample (n=20).
We also tested whether donepezil, an acetylcho-
linesterase inhibitor, could improve behavioural 
outcomes. Studies in rats and bats have shown that 
modulating the cholinergic pathway from nucleus 
basalis to auditory cortex enhances experience-de-
pendent plasticity,13 whereas suppression of the 
cholinergic system reduces it.14 15 As the cholinergic 
system is specifically involved in behaviourally 
dependent learning,16 cholinergic drugs may be most 
effective when paired with behavioural therapy. Two 
clinical trials in aphasia by Berthier and colleagues17 
18 administered donepezil in conjunction with 
conventional speech and language therapy. The 
drug improved aphasia quotient scores, particularly 
on picture naming. While Berthier and colleagues 
studies included patients with aphasia of all types, 
we focused on Wernicke’s and global aphasia and 
tested whether aphasia severity interacted with the 
efficacy of both phonological and donepezil thera-
pies using a within-subject, cross-over design.
As well as behavioural outcome measures, we 
employed functional neuroimaging to investi-
gate the neural mechanisms of the therapeutic 
effect. Following Teki and colleagues,19 changes 
in the auditory cortex’s sensitivity to phonological 
contrasts were assayed using the mismatch negativity 
response (MMN) recorded with magnetoenceph-
alography (MEG). Participants were habituated to 
a repeated spoken syllable (the standard stimulus). 
Occasionally, syllables that differed acoustically or 
phonologically from the standard stimulus were 
presented (the deviant stimuli). The surprise elic-
ited by these unanticipated deviant stimuli results 
in a stronger evoked neural response, known as 
the MMN.20 By comparing MMN responses with 
acoustic and phonemic deviants, we could reveal 
when and where neurons were sensitive to the 
phonological content of the stimuli.
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Dynamic causal modelling (DCM)21–23 was used to investi-
gate how the MMN arises from interactions between multiple 
neuronal sources in the temporal lobes. Teki and colleagues 
showed that in controls the difference between acoustic and 
phonemic deviants was reflected in stronger local adaptation of 
representations in the bilateral primary auditory cortex (Heschl’s 
gyrus (HG)) and the auditory association cortex (superior 
temporal gyrus (STG)). Patients with aphasia showed no such 
adaptation in the left HG or STG, but instead showed stronger 
feedforward connectivity on the right hemisphere. This study 
involved the same participants, MMN paradigm and analysis, 
but employed a longitudinal design to test the impact of phono-
logical training and donepezil on connectivity. We hypothesised 
that an effective therapy would increase updating of phonolog-
ical representations on the left hemisphere and decrease reliance 
on the right hemisphere regions.
MATERIALS AND METHODS
Study design
Our objectives were to investigate (1) whether phonological 
training improved speech comprehension, (2) whether donepezil 
facilitated phonological training effects and (3) the impact of the 
therapies on directed connectivity within the auditory network.
A randomised, double-blind, placebo-controlled cross-over 
design was used (figure 1). Each participant received four 5-week 
blocks of treatment:
 ► drug only (5 mg daily dose of donepezil)
 ► drug and Earobics (10 mg daily dose of donepezil, plus 
two 40 min daily sessions of Earobics)
 ► placebo only
 ► placebo and Earobics.
Participants were assessed at baseline, then before (1) and 
after (2) phonological training, in both drug (D) and placebo 
(P) conditions, leading to five distinct assessment time points: 
baseline, D1, D2, P1 and P2. This design allowed a factorial 
analysis of behavioural and effective connectivity outcome 
measures, comparing performance before (D1 and P1) versus 
after phonological training (D2 and P2), and when participants 
were receiving donepezil (D1 and D2) versus placebo (P1 and 
P2). There were no predetermined criteria for termination of the 
trial or the definition of outliers.
Participants were assigned to one of two cross-over groups 
(drug then placebo or placebo then drug). Block randomisation 
with bias minimisation was used: a computer algorithm gener-
ated a random number to allocate each new participant to a 
group. An independent researcher ensured that the cross-over 
groups did not become unbalanced by more than four patients. 
Participants, caregivers and researchers were blind to block allo-
cation. Randomisation codes were held by the study pharmacist. 
Tablets were supplied in bottles labelled with the block number 
when they should be taken (1–4). Each bottle contained 35 indis-
tinguishable lactose encapsulated tablets of placebo, 5 mg done-
pezil hydrochloride or 10 mg donepezil hydrochloride.
Outcome measures were prospectively selected. The primary 
behavioural outcome measure was score on the comprehensive 
aphasia test (CAT)24 speech comprehension scale (including 
word, sentence and paragraph comprehension; maximum 
score=66, aphasia cut-off=56), which was chosen for its high 
ecological validity. Other CAT measures (written comprehen-
sion, speech repetition, naming, reading and writing) and a 
sustained attention to response test (SART)25 were the secondary 
outcomes. The primary neuroimaging outcome was the effect of 
phonemic deviants on effective connectivity within the auditory 
network.
Participants
The participants were patients with chronic post-stroke aphasia. 
As the study required approval from the Medicines and Health-
care Products Regulatory Agency, which deemed the study a 
clinical trial of an investigational medicinal product, the power 
calculation was based on the drug effect. The best evidence 
available at the time of designing the study (from Berthier and 
colleagues, who used donepezil to treat post-stroke aphasia),17 
indicated that 20 patients would be required to detect a 5% 
difference given a 7% within-person SD, 5% significance level 
and 90% power. Data collection occurred from November 2006 
to August 2009 and ended when 20 patients had completed the 
protocol. Twenty-seven patients were enrolled, three withdrew 
after the baseline time point due to the trial’s time demands and 
a further four were excluded from the analysis as extensive left 
auditory cortex damage made them unsuitable for the DCM 
analysis (figure 2). We report the results from the remaining 20 
Figure 1 Study design showing order of the five time points (baseline, D1, D2, P1 and P2) for the two cross-over groups.
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patients. Baseline data from all 20 participants were previously 
reported by Teki and colleagues.19
All participants had left hemisphere stroke and normal 
hearing (three female; mean age (range)=62.4 (43–90) years; 
average time since stroke=3.3 (0.6–8.6) years; average lesion 
volume=127.3 (24.2–403.6) cm3). The demographics, lesion 
details and baseline behavioural scores are shown in table 1. The 
behavioural inclusion criteria were speech production impair-
ment in CAT repetition and/or CAT naming, and speech compre-
hension impairment in CAT spoken word comprehension, CAT 
spoken sentence comprehension and/or a custom-made vowel 
identification task.
During recruitment, it was assumed (wrongly as it turned out) 
that the participants’ scores on the main outcome measure would 
be normally distributed. It became apparent after the study 
closed that they fell into two groups (moderate and severe), as 
discussed in a previous report by Schofield and colleagues.26 
None of the participants had the sample mean as their baseline 
score. A cluster analysis confirmed this bimodal distribution. We 
then treated the two groups as a factor in all further analyses, 
including when testing the main hypothesis. Group membership, 
moderate or severe, is listed in table 1.
The participants were classified into aphasia subtypes 
depending on their speech production abilities. Those whose 
object naming and repetition total scores placed them in the 
bottom quartile for subjects with aphasia in the Predicting 
Language Outcome and Recovery After Stroke (PLORAS) data-
base27 were classed as global (G); otherwise we classified them 
as Wernicke’s aphasics (W). The majority of severe patients (six 
out of eight) had global aphasia (see table 1). A χ2 test showed no 
significant differences between the two therapy groups in terms 
of aphasia subtype (c2(1, n=20)=0.74, p=0.65).
All participants provided written informed consent according 
to the Declaration of Helsinki. Data were collected at the Insti-
tute of Neurology, University College London, and the study 
was approved by the Joint Research Ethics Committee of the 
National Hospital for Neurology and Neurosurgery and the 
Institute of Neurology, University College London.
Phonological training
The phonological training software was Earobics version 1 
for adolescents and adults.12 Earobics cycles through six inde-
pendently adaptive tasks: (1) ‘memory matrix’, environmental 
sound-to-picture matching to train auditory short-term memory; 
(2) ‘sound check’, two-alternative forced-choice task to probe 
grapheme-to-phoneme mapping; (3) ‘get rhythm’, non-speech 
and speech sounds to probe auditory segmentation; (4) ‘connec-
tivity’, compound word-to-picture matching to train phonological 
blending; (5) ‘rhyme time’, rhyme detection task using sequences 
of increasing numbers of words and (6) ‘same-different’, auditory 
discrimination using phoneme and word pairs. The participants 
were asked to complete 10 hours of training per week over each 
5-week training block and record training duration in self-report 
diaries with some help from their partner or carer.
Figure 2 Consolidated Standards of Reporting Trials (CONSORT) trial flow diagram.
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Drug administration and monitoring
Donepezil dosage was determined according to the British 
National Formulary guidelines, starting at 5 mg for the first 
5-week block. If this was tolerated, dose was escalated to 10 mg 
for the second block. All patients except one (patient 17) esca-
lated to the higher dose. Adverse effects were monitored at every 
time point using a checklist of all possible adverse events (see 
online supplementary table).
Behavioural outcome measures
The CAT24 was administered at every time point as shown in 
figure 1. Only data from D1, D2, P1 and P2 time points were 
entered into the statistical analysis. Domain-general (non-verbal) 
effects of donepezil were tested using a modified version of the 
SART, a Go/No-Go task loading on sustained attention,25 presented 
with E-Prime28 and administered at baseline, D2 and P2 sessions 
only. The SART outcome measures included average reaction time 
for correct Go trials, accuracy of response inhibition for No-Go 
trials and post-error slowing. We also collected carer-reported 
measures of activity and participation from the Social Commu-
nication and Daily Planning from the Functional Assessment of 
Communication Skills for Adults (ASHA FACS)29 at all time points.
Structural MRI
A T1-weighted structural brain image with 1 mm3 voxel size was 
acquired with a Siemens Sonata 1.5T MRI scanner at baseline. 
The Automated Lesion Identification toolbox30 for SPM831 iden-
tified lesion location and volume.
MEG and electroencephalogram data acquisition
The evoked response potentials were collected at D1, D2, P1 and 
P2 time points. MEG was used in 18 subjects, on a CTF systems 
274-channel whole-head MEG scanner with third-order axial 
gradiometres and a sampling rate of 480 Hz. Electroencepha-
logram (EEG) was used in two subjects (patients 8 and 19) due 
to MEG artefacts. EEG data were acquired with a high-density, 
128-channel Bio-Semi headcap system, with a sampling rate of 
512 Hz.
MEG/EEG experimental paradigm and stimuli
Spoken auditory stimuli were presented binaurally in a passive 
oddball paradigm, with the standard stimulus ‘Bart’, an acoustic 
deviant, and two phonemic deviants ‘burt’ and ‘beat’. The deviant 
stimuli were created by varying the frequencies of the standard’s 
first and second formants, as described by Teki and colleagues.19 
At each time point, four stimuli blocks were presented, each 
containing 120 presentations of the standard and 30 presenta-
tions of each deviant in a pseudo-randomised order. Stimulus 
onset asynchrony was 1080 ms. Stimulus amplitude was initially 
set at 60 dB/sound pressure level and adjusted prior to scanning 
to a comfortable level.
The participants were instructed to attend to an incidental 
visual detection task while ignoring the auditory stimuli. Pictures 
of outdoor scenes were presented for 60 s, followed by a circle 
(92% of trials) or square (8% of trials) for 1.5 s. The partici-
pants responded by button press to the circle and withheld their 
response for the square. Average response accuracy was 87%, 
Table 1 Demographics, lesion details and baseline behavioural performance of the patients with aphasic stroke
ID Group Sex
Hand-
edness Severity
Aphasia
subtype
Age at 
baseline 
(years)
Time 
since 
stroke 
(years)
Type 
of 
stroke
Lesion 
volume 
(cm3)
% of ROI 
damaged Speech comprehension Speech production
Left A1
Left 
STG
CAT word 
comp. (/30)
CAT sentence 
comp. (/32)
Vowel 
ID
(/40)
CAT 
repetition
(/74)
CAT object 
naming 
(/48)
1 1 M L M G 69.6 1.0 I 69.5 1.8 0.0 29 28 27 28 6
2 2 M R M W 62.7 1.2 I 42.4 7.2 21.1 30 22 38 34 38
3 1 M R M W 63 8.6 I 429.3 81.0 43.3 27 21 17 50 22
4 1 M L M W 61.5 7.6 I 314.0 52.9 0.0 23 25 16 38 12
5 1 M R M W 67.8 7.4 H 64.3 8.1 30.5 29 21 37 50 30
6 2 M R M W 60.5 5.6 I 161.1 52.7 9.3 27 30 34 54 27
7 1 M R M W 64.9 1.2 I 171.1 39.7 17.9 27 21 38 60 33
8 1 M R S G 61.4 1.9 I 242.9 52.6 52.6 24 6 16 0 0
9 2 F R S G 66.5 5.3 I 195.2 42.3 21.4 21 15 13 23 12
10 1 M R M W 61.5 3.4 M-L* 1.6 0.0 0.0 26 26 40 63 36
11 1 M R S G 63.3 0.6 I 69.0 8.3 33.5 20 13 12 0 0
12 2 F R S G 43.5 1.3 I 69.7 68.7 46.1 14 17 17 18 14
13 2 F R S W 46.3 0.7 I 31.7 60.9 15.3 26 12 26 26 41
14 2 M R S G 71.1 5.1 I 151.1 79.5 29.8 20 14 7 0 0
15 2 M R S G 62.4 3.7 I 168.6 20.2 0.0 22 11 21 30 0
16 1 M R M W 60.9 3.0 H 136.6 11.7 1.5 28 26 40 68 37
17 1† M R M G 45.4 3.7 I 61.2 5.8 16.7 27 21 39 31 18
18 2 M R M W 74.7 0.6 I 41.1 7.3 2.9 24 26 24 45 14
19 2 M R M G 50.2 1.8 I 280.5 29.5 0.9 25 26 39 28 2
20 1 M R M W 90.3 3.7 I 62.9 14.2 0.0 27 21 34 68 43
Behavioural measures included CAT spoken word comprehension (score cut-off for impaired performance=25), CAT spoken sentence comprehension (cut-off=27), vowel 
identification (36), CAT total repetition score (67) and CAT object naming (43). Values highlighted in bold indicate scores below the threshold for normal performance.
*Patient 10 had four small lacunes in the left hemisphere: (1) superior and lateral occipital lobe (I); (2) deep to the superior frontal sulcus (I); (3) superior longitudinal fasciculus 
(L) and (4) inferomedial thalamus (L).
†Patient 17 failed to escalate to 10 mg of donepezil in the second drug block and remained on 5 mg for both blocks.
CAT, comprehensive aphasia test; I, infarct; H, haemorrhagic; M-L, multilacune; ROI, region of interest; STG, superior temporal gyrus.
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with no significant differences in the number of errors (false-pos-
itives or false-negatives) as an effect of time (main effect of 
chronological order of testing sessions) or due to drug adminis-
tration (main effect of drug vs placebo).
MEG/EEG preprocessing
Preprocessing of MEG data in SPM831 included the following: 
high-pass filtering (1 Hz), eye-blink artefact removal using 
multiple source eye correction,32 epoching (−100 to 500 ms 
peristimulus time), baseline correction (−100 to 0 ms prestim-
ulus time window), low-pass filtering (30 Hz), merging the four 
blocks of each dataset, robust averaging and low-pass filtering 
again. Preprocessing of EEG data in SPM1231 33 included the 
following: high-pass filtering (1 Hz), epoching (−100 to 500 ms 
peristimulus time), merging the four runs of each dataset, identi-
fication of blinks from vertical electro-oculography data, correc-
tion of blink artefacts using single value decomposition and 
signal-space projection, robust averaging and low-pass filtering 
(30 Hz). (Note: Low-pass filtering at 30 Hz would have removed 
any time-locked effects in the gamma range from our analyses.)
Source localisation using the variational-Bayesian equivalent 
current dipoles34 is described in the online supplementary material. 
In brief, this compared different source models, containing five 
possible sources identified from previous auditory MMN analyses 
(left and right HG, left and right STG and right IFG) in different 
combinations. The winning model, containing left and right HG 
and STG only (p=0.88), was used as the spatial model for the DCM 
analysis. All patients had at least 10% intact cortex within each 
anatomical region of interest. All fitted sources fell within intact 
cortex, not lesion (see online supplementary material for detail).
Dynamic causal modelling
DCM was conducted on preprocessed evoked responses to stan-
dard and deviant stimuli at each time point separately (D1, D2, 
P1 and P2). Evoked responses from 1 to 400 ms peristimulus time 
were tapered with a Hanning window. The DCM spatial model 
used Equivalent Current Dipole (ECD) sources from bilateral HG 
and STG dipole locations (see online supplementary material). The 
neural model included exogenous auditory stimulation to the left 
and right HG nodes at 60 ms; endogenous connectivity evoked by 
standard stimuli in two forward, two backward and four lateral 
connections between HG and STG sources (diagonal connections 
were not modelled because although heterotopic connections are 
present in auditory cortex they are sparse)35 ; and three modula-
tory effects evoked by each deviant stimulus compared with the 
standard stimulus. A large model space of 2^8 (256) models was 
estimated, each with modulatory effects modelled in a different 
combination of the eight independent inter-regional connections. 
Modulatory effects on self-connections, modelling a region’s 
sensitivity to inputs,36 were present in all models.
Bayesian model averaging
For each connection, Bayesian Model Averaging (BMA) with 
random effects37 was used at the subject level to average the 
modulation caused by each deviant versus the standard at each 
time point (D1, D2, P1 and P2). The difference in modulation 
by phonemic versus acoustic deviants (phonemic sensitivity) 
was calculated by averaging the modulatory effects for the two 
phonemic deviants and subtracting the modulatory effect for the 
acoustic deviant.
The phonemic sensitivity values were entered into a repeat-
ed-measures analysis of variance (ANOVA) for each connec-
tion. The ANOVAs had within-subjects variables time (before/
after phonological training) and drug (on drug/placebo), and 
between-subjects variables severity (moderate/severe groups) 
and cross-over order (drug/placebo first).
RESULTS
Baseline language performance and structural MRI
Exploratory analysis of the baseline CAT speech comprehen-
sion scores using a two-step cluster analysis identified a division 
between participants with moderate (n=13) and severe (n=7) 
impairments (figure 3). Independent samples t-tests confirmed that 
moderate and severe subgroups differed in speech comprehension 
ability (t(18)=7.77, p<0.001), as well as in written comprehen-
sion, repetition, naming, reading and writing abilities (all p<0.05). 
The subgroups did not differ significantly in age (p=0.35) or time 
since stroke (p=0.43). Lesion overlay maps (figure 3) showed the 
subgroups shared broadly similar lesion distributions, centring on 
the left perisylvian cortex and superior longitudinal fasciculus. 
The lesion volume was not significantly different between groups 
(p=0.94).
Phonological training dose
Out of 40 completed training blocks (2 blocks × 20 partici-
pants), 28 self-report diaries were fully completed (70%). Of 
those 28 diaries, the average training dose was 36 hours 38 min 
per block (SD=16 hours 8 min; range: 6 hours 20 min to 65 hours 
5 min; median=36 hours 28 min). Fifteen of the 28 diaries were 
from blocks 1 and 13 were from Block 2. The mean training 
dose for block 1 and block 2 did not differ significantly (block 
1: mean=38 hours 58 min; block 2: mean=36 hours 26 min; 
t(26)=0.37, p=0.71).
Compliance and tolerability of cholinergic drug therapy
Patients were required to return their medication bottles after 
completing each block. Eighty-eight per cent of medication 
bottles were returned. In these bottles, only 2.5% of unused 
tablets remained.
The participants completed an adverse effects report form at 
each time point (see online supplementary table). Three partic-
ipants had incomplete report forms at one time point; hence, 
reports were analysed for 17 participants only. We compared 
the total number of adverse events when the participants were 
on drug (D1 or D2) or placebo (P1 or P2). The participants 
reported 32 adverse events when on drug and 28 on placebo. A 
non-parametric sign test showed no significant difference in the 
frequency of adverse events on drug versus placebo (p=0.79).
The most frequent adverse events were insomnia, head-
aches, dizziness and muscle cramps. For each type of event, the 
frequency of occurrence on drug or placebo was compared using 
the McNemar tests with binomial distribution. No significant 
differences were observed for any type of event (all p>0.2).
Therapy effects on behavioural outcome measures: primary 
outcomes
The effects of phonological training and donepezil on CAT speech 
comprehension scores were assessed using a mixed effects ANOVA 
with two within-subjects variables: (1) time (before/after phonolog-
ical training) and (2) drug (on drug/on placebo). Two between-sub-
jects variables were also included: (1) aphasia severity (moderate/
severe) and (2) cross-over group (drug first/placebo first). The 
results (figure 4) demonstrated that phonological training signifi-
cantly improved speech comprehension, indicated by a significant 
main effect of time (F(1, 16)=6.56, p<0.05). Conversely, there 
was a significant main effect of drug, with (unexpectedly) lower 
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scores on drug than placebo (F(1, 16)=11.60, p<0.005). There 
was no interaction between phonological training and donepezil: 
the effects were independent and in opposite directions. Time by 
severity and drug by severity interactions were significant (F(1, 
16)=6.6, p<0.05 and F(1, 16)=4.9, p<0.05, respectively): both 
therapy effects were larger in the severe patient group.
Therapy effects on behavioural outcome measures: secondary 
outcomes
Among the other CAT measures (written comprehension, speech 
repetition, naming, reading and writing), the only notable 
effect was a significant time by severity interaction for written 
comprehension (F(1, 16)=8.56, p<0.05), driven by larger bene-
ficial effects of phonological training in severe patients compared 
with moderate patients. There was a non-significant trend towards 
better naming on drug than placebo (F(1, 16)=3.64, p=0.075), 
consistent with prior observations by Berthier and colleagues.17 18
There were no significant changes in the SART or ASHA FACS 
scores. Repeated-measures ANOVAs demonstrated no signifi-
cant effects of time, drug, severity or cross-over group.
Therapy effects on effective connectivity
MMN responses to acoustic and phonemic deviants are shown 
in the online supplementary figure 1.
Figure 3 Baseline Comprehensive Aphasia Test data and structural brain imaging. Top: average T-scores for severe (n=7) and moderate (n=13) patients. 
Bottom left: speech comprehension T-scores, showing division of severe and moderate subgroups. Bottom right: lesion overlay maps for severe and moderate 
patients.
Figure 4 Effects of Earobics and donepezil on speech comprehension in severe and moderate patient subgroups.
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Modulation of connection strength by phonemic versus acoustic 
deviants (phonemic sensitivity) changed as a result of phonological 
training (figure 5). The main effects of phonological training were 
significant in two connections (figure 5A): (1) the left STG self-con-
nection (F(1, 16)=5.30, p<0.05) and (2) the left HG to left STG 
connection (F(1, 16)=11.3, p<0.005). Three connections showed 
time by severity interactions driven by stronger training effects in 
the severe group (figure 5B): (1 ) the left HG to left STG forward 
connection (F(1, 16)=8.30, p<0.05) (2) the left STG to right STG 
lateral connection (F(1, 16)=6.65, p<0.05) and (3) the right STG 
to left STG lateral connection (F(1, 16)=8.64, p<0.01).
Only one connection, the left HG to STG, showed a main 
effect of drug (F(1, 16)=20.70, p<0.001) due to stronger 
phonemic sensitivity on drug versus placebo (figure 5C). A 
drug by severity interaction (figure 5D) showed that this effect 
was larger for severe than moderate patients (F(1, 16)=9.79, 
p<0.01).
DISCUSSION
We hypothesised that phonological training would improve 
speech comprehension and that donepezil would facilitate this 
effect by enhancing the neuroplastic response to training. Only 
the first hypothesis was supported: patients showed significantly 
better speech comprehension after phonological training, but 
worse comprehension on drug than placebo. Both effects were 
stronger in more severely impaired patients: the severe subgroup 
responded better to training and worse to drug than the moderate 
subgroup. The effect of phonological training on comprehen-
sion was significant but clinically small: the average CAT speech 
comprehension score during the placebo block increased from 
52.0 to 53.2 after 5 weeks of training. The average dose was 
36 hours per block. Lower doses of phonological therapy in 
previous studies (6–12 hours) may explain why significant effects 
have not been consistently observed.10 11 Although the effect of 
phonological training was small, it is of clinical importance as 
therapeutic interventions in patients with aphasia with severe 
impairments of speech perception have been largely written 
off, both in textbooks (‘(global aphasia is) sometimes known as 
irreversible aphasia syndrome’38) and in systematic reviews (‘No 
evidence of benefit’39).
The behavioural effect of phonological training was gener-
alised in two ways: first, training with Earobics stimuli gener-
alised to different stimuli used in CAT speech comprehension 
tests and second, written comprehension improved, at least for 
severe patients. This latter result suggests that either auditory 
training acted on amodal, higher level semantic representations 
or that strengthening auditory phonological representations 
also facilitates grapheme-to-phoneme translation required for 
written comprehension. A third option, that training improved 
non-linguistic, domain-general cognitive abilities, is less likely as 
there were no improvements on sustained attention.
The surprising result that speech comprehension was worse 
on donepezil than placebo contrasts with improved Western 
Aphasia Battery Aphasia Quotients40 was reported by Berthier 
Figure 5 Significant changes in phonemic sensitivity between time points. (a) Red connections showed significantly stronger phonemic sensitivity after 
Earobics training (main effect of Earobics); (b) red connections showed significantly stronger training effects on phonemic sensitivity in the severe patients 
than the moderate patients (Earobics by severity interaction); (c) main effect of drug and (d) drug by severity interaction.
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and colleagues.17 18 Berthier only observed task-specific improve-
ments for picture naming. We saw a trend towards better 
naming on drug than placebo, perhaps suggesting that donepezil 
is better suited to treating speech production than comprehen-
sion. Husain and Mehta41 observe that cognitive-enhancement 
drugs can have opposing effects on different tasks as an inverted 
U-shaped relationship applies between neuropharmacological 
enhancement and performance. Hence, if acetylcholine stimu-
lation was already high in auditory cortex, increasing it further 
with donepezil could have impaired performance.
The effective connectivity (DCM) analysis examined the inter-
actions between auditory areas. We predicted that improved 
speech comprehension would result from a tuning of phono-
logical representations in auditory cortex. In DCM such tuning 
is expressed as a region’s self-connection, which acts as a gain 
mechanism36: that is, a post-therapy increase in a self-connec-
tion’s strength would mean that the region had become more 
sensitive to phonological contrasts. The results confirmed our 
hypothesis: improved speech comprehension after phonolog-
ical training was associated with stronger modulation of the left 
STG’s self-connection by phonological but not acoustic devi-
ants.
Phonological training also strengthened phonological sensi-
tivity of the forward connection from left HG to STG, suggesting 
that updating of higher order representations of speech sounds 
in the left STG was driven by stronger feedforward prediction 
errors. The observation that phonological modulation of this 
connection was also affected by drug (which did not result in 
a behavioural improvement) suggests that strengthening this 
forward connection alone is insufficient to improve speech 
comprehension.
Our findings were not confined to the left hemisphere. In 
severe patients, training led to stronger phonemic sensitivity in 
the STG interhemispheric connections. This implies that after 
severe left temporal damage, the left STG requires more support 
from its right hemisphere homologue to perform phonolog-
ical discrimination. The baseline data in these patients treated 
as a single group19 showed that modulation strength of the left 
to right STG connection correlated negatively with phonemic 
discrimination ability; that is, there was a decoupling of these two 
regions in patients with better speech perception. It is not clear 
whether this decoupling represented (1) the best the damaged 
system could currently manage, with the left and right STGs 
maintaining their specialised functions but no longer working 
in tandem or (2) a maladaptive response to left-hemisphere 
damage that may serve to limit further recovery, as, presumably, 
auditory representations in the right hemisphere do not share 
the linguistic specialisation of the left hemisphere. The longitu-
dinal data presented here suggest a more complex interpretation 
because severity effects indicated (1) moderately affected patients 
do not have impaired interhemispheric connectivity and therapy 
effects are seen within their dominant temporal lobe and (2) in 
more severely affected patients interhemispheric processing of 
phonemic stimuli is abnormal, but can still be improved by audi-
tory training.
In conclusion, our results demonstrate that phonological 
training worked at a behavioural level, but the underlying neuro-
anatomical mechanism varied with aphasia severity. The left STG 
mediated therapy effects in both patient groups: in the moderate 
group, this occurred independently from the influence of right 
temporal regions, whereas in the severe group interhemispheric 
interactions were also involved in promoting recovery of speech 
perception.
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